Evogene (EVGN) Tops Q1 EPS by 26c
Tweet
Share
E-mailGet Alerts EVGN Hot Sheet
Join SI Premium – FREE
Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.06), $0.26 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $334 thousand versus the consensus estimate of $3 million.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karooooo Ltd. (KARO) Tops Q2 EPS by 76c
- Morgan Stanley Downgrades Anima Holding SA (ANIM3:BZ) to Equalweight
- AgPlenus Launches Novel AI Model for Predicting Antifungal Potency, Expanding ChemPass AI for Ag™ Capabilities
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
